Multispecifics are transforming the CDMO development architecture
BioSpace
Manufacturers are being pushed beyond mAbera platforms into a new design model built around molecular engineering, complex analytics and amplified upstream and downstream processing.
pharminent
August 28, 2026 (Last updated: September 1, 2026)
BioSpace
Manufacturers are being pushed beyond mAbera platforms into a new design model built around molecular engineering, complex analytics and amplified upstream and downstream processing.
